Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James O Armitage

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
American Journal of Hematology|April 18, 2012
The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and managementJames O Armitage
Targeted Oncology|April 4, 2009
Targeted therapy and hematological malignancyJames O Armitage
Current Hematology Reports|August 23, 2003
The evolving role of autologous hematopoietic stem cell transplantation for the treatment of patients with lymphomaJames O Armitage
Cancer Journal (Sudbury, Mass.)|September 26, 2012
From the guest editor: pressing questions in the care of patients with lymphomasJames O Armitage
Blood|March 16, 2007
How I treat patients with diffuse large B-cell lymphomaJames O Armitage
Oncology (Williston Park, N.Y.)|February 19, 2013
A new look at an old syndromeJames O Armitage
Oncology (Williston Park, N.Y.)|June 20, 2008
Professionalism and cancer careJames O Armitage
American Journal of Hematology|June 3, 2015
The aggressive peripheral T-cell lymphomas: 2015James O Armitage
The New England Journal of Medicine|March 25, 2005
Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progressJames O Armitage
Current Hematologic Malignancy Reports|June 15, 2011
The importance of testing PET-directed therapy in patients with Hodgkin lymphomaJames O Armitage
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
American Journal of Hematology|April 18, 2012
The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and managementJames O Armitage
Targeted Oncology|April 4, 2009
Targeted therapy and hematological malignancyJames O Armitage
Current Hematology Reports|August 23, 2003
The evolving role of autologous hematopoietic stem cell transplantation for the treatment of patients with lymphomaJames O Armitage
Cancer Journal (Sudbury, Mass.)|September 26, 2012
From the guest editor: pressing questions in the care of patients with lymphomasJames O Armitage
Blood|March 16, 2007
How I treat patients with diffuse large B-cell lymphomaJames O Armitage
Oncology (Williston Park, N.Y.)|February 19, 2013
A new look at an old syndromeJames O Armitage
Oncology (Williston Park, N.Y.)|June 20, 2008
Professionalism and cancer careJames O Armitage
American Journal of Hematology|June 3, 2015
The aggressive peripheral T-cell lymphomas: 2015James O Armitage
The New England Journal of Medicine|March 25, 2005
Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progressJames O Armitage
Current Hematologic Malignancy Reports|June 15, 2011
The importance of testing PET-directed therapy in patients with Hodgkin lymphomaJames O Armitage
Pageof 26